Literature DB >> 25947319

Estimation of future PM2.5- and ozone-related mortality over the continental United States in a changing climate: An application of high-resolution dynamical downscaling technique.

Jian Sun1, Joshua S Fu, Kan Huang, Yang Gao.   

Abstract

UNLABELLED: This paper evaluates the PM2.5- and ozone-related mortality at present (2000s) and in the future (2050s) over the continental United States by using the Environmental Benefits Mapping and Analysis Program (BenMAP-CE). Atmospheric chemical fields are simulated by WRF/CMAQ (horizontal resolution: 12×12 km), applying the dynamical downscaling technique from global climate-chemistry model under the Representative Concentration Pathways scenario (RCP 8.5). Future air quality results predict that the annual mean PM2.5 concentration in continental U.S. decreases nationwide, especially in the Eastern U.S. and west coast. However, the ozone concentration is projected to decrease in the Eastern U.S. but increase in the Western U.S. Future mortality is evaluated under two scenarios (1) holding future population and baseline incidence rate at the present level and (2) using the projected baseline incidence rate and population in 2050. For PM2.5, the entire continental U.S. presents a decreasing trend of PM2.5-related mortality by the 2050s in Scenario (1), primarily resulting from the emissions reduction. While in Scenario (2), almost half of the continental states show a rising tendency of PM2.5-related mortality, due to the dominant influence of population growth. In particular, the highest PM2.5-related deaths and the biggest discrepancy between present and future PM2.5-related deaths both occur in California in 2050s. For the ozone-related premature mortality, the simulation shows nation-wide rising tendency in 2050s under both scenarios, mainly due to the increase of ozone concentration and population in the future. Furthermore, the uncertainty analysis shows that the confidence interval of all causes mortality is much larger than that for specific causes, probably due to the accumulated uncertainty of generating datasets and sample size. The confidence interval of ozone-related all cause premature mortality is narrower than the PM2.5-related all cause mortality, due to its smaller standard deviation of the concentration-mortality response factor. IMPLICATIONS: The health impact of PM2.5 is more linearly proportional to the emission reductions than ozone. The reduction of anthropogenic PM2.5 precursor emissions is likely to lead to the decrease of PM2.5 concentrations and PM2.5 related mortality. However, the future ozone concentrations could increase due to increase of the greenhouse gas emissions of methane. Thus, to reduce the impact of ozone related mortality, anthropogenic emissions including criteria pollutant and greenhouse gas (i.e. methane) need to be controlled.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25947319     DOI: 10.1080/10962247.2015.1033068

Source DB:  PubMed          Journal:  J Air Waste Manag Assoc        ISSN: 1096-2247            Impact factor:   2.235


  11 in total

1.  Monetized health benefits attributable to mobile source emission reductions across the United States in 2025.

Authors:  Philip Wolfe; Kenneth Davidson; Charles Fulcher; Neal Fann; Margaret Zawacki; Kirk R Baker
Journal:  Sci Total Environ       Date:  2018-09-21       Impact factor: 7.963

2.  Ozone-related asthma emergency department visits in the US in a warming climate.

Authors:  Nicholas Nassikas; Keith Spangler; Neal Fann; Christopher G Nolte; Patrick Dolwick; Tanya L Spero; Perry Sheffield; Gregory A Wellenius
Journal:  Environ Res       Date:  2020-01-31       Impact factor: 6.498

3.  Development and evaluation of an advanced National Air Quality Forecasting Capability using the NOAA Global Forecast System version 16.

Authors:  Patrick C Campbell; Youhua Tang; Pius Lee; Barry Baker; Daniel Tong; Rick Saylor; Ariel Stein; Jianping Huang; Ho-Chun Huang; Edward Strobach; Jeff McQueen; Li Pan; Ivanka Stajner; Jamese Sims; Jose Tirado-Delgado; Youngsun Jung; Fanglin Yang; Tanya L Spero; Robert C Gilliam
Journal:  Geosci Model Dev       Date:  2022-04-21       Impact factor: 6.892

4.  A Risk and Decision Analysis Framework to Evaluate Future PM2.5 Risk: A Case Study in Los Angeles-Long Beach Metro Area.

Authors:  Bowen He; Qun Guan
Journal:  Int J Environ Res Public Health       Date:  2021-05-04       Impact factor: 3.390

5.  Characterizing the impact of projected changes in climate and air quality on human exposures to ozone.

Authors:  Kathie L Dionisio; Christopher G Nolte; Tanya L Spero; Stephen Graham; Nina Caraway; Kristen M Foley; Kristin K Isaacs
Journal:  J Expo Sci Environ Epidemiol       Date:  2017-01-25       Impact factor: 5.563

Review 6.  The Interplay of Climate Change and Air Pollution on Health.

Authors:  H Orru; K L Ebi; B Forsberg
Journal:  Curr Environ Health Rep       Date:  2017-12

7.  Impacts of climate change on future air quality and human health in China.

Authors:  Chaopeng Hong; Qiang Zhang; Yang Zhang; Steven J Davis; Dan Tong; Yixuan Zheng; Zhu Liu; Dabo Guan; Kebin He; Hans Joachim Schellnhuber
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-12       Impact factor: 11.205

8.  Future ozone-related acute excess mortality under climate and population change scenarios in China: A modeling study.

Authors:  Kai Chen; Arlene M Fiore; Renjie Chen; Leiwen Jiang; Bryan Jones; Alexandra Schneider; Annette Peters; Jun Bi; Haidong Kan; Patrick L Kinney
Journal:  PLoS Med       Date:  2018-07-03       Impact factor: 11.069

9.  Future Fire Impacts on Smoke Concentrations, Visibility, and Health in the Contiguous United States.

Authors:  B Ford; M Val Martin; S E Zelasky; E V Fischer; S C Anenberg; C L Heald; J R Pierce
Journal:  Geohealth       Date:  2018-08-03

Review 10.  How will air quality effects on human health, crops and ecosystems change in the future?

Authors:  Erika von Schneidemesser; Charles Driscoll; Harald E Rieder; Luke D Schiferl
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2020-09-28       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.